Dudley Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Buy
19,376
+8
+0% +$936 0.99% 25
2026
Q1
$2.33M Buy
19,368
+8
+0% +$924 1.03% 25
2025
Q4
$2.04M Buy
19,360
+741
+4% +$69.6K 0.89% 28
2025
Q3
$1.56M Sell
18,619
-139
-0.7% -$11.4K 0.7% 36
2025
Q2
$1.48M Sell
18,758
-311
-2% -$24.7K 0.74% 36
2025
Q1
$1.71M Sell
19,069
-67
-0.4% -$6.26K 0.9% 36
2024
Q4
$1.9M Sell
19,136
-14
-0.1% -$1.44K 0.96% 29
2024
Q3
$2.17M Buy
19,150
+7
+0% +$832 1.12% 23
2024
Q2
$2.37M Sell
19,143
-294
-2% -$37.9K 1.31% 19
2024
Q1
$2.55M Buy
19,437
+322
+2% +$39.7K 1.49% 17
2023
Q4
$2.08M Sell
19,115
-309
-2% -$32.1K 1.33% 22
2023
Q3
$2M Buy
19,424
+767
+4% +$82.7K 1.4% 20
2023
Q2
$2.15M Buy
18,657
+1,277
+7% +$145K 1.45% 19
2023
Q1
$1.85M Buy
17,380
+23
+0.1% +$2.48K 1.26% 24
2022
Q4
$1.93M Buy
+17,357
New +$1.77M 1.35% 20

Other funds holding MRK

Dudley Capital Management's MRK Position: Q2 2026 in Review

Dudley Capital Management increased its Merck (MRK) stake by 0.04% in Q2 2026, buying an estimated $936 and bringing the position to 19,376 shares worth $2.49M. The position accounts for 0.99% of the portfolio, ranked #25.

Dudley Capital Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.55M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Dudley Capital Management held 19,376 shares of Merck worth $2.49M as of Q2 2026.
  • Dudley Capital Management bought 8 Merck shares in Q2 2026, an estimated $936.
  • Merck made up 0.99% of Dudley Capital Management's portfolio in Q2 2026, its #25 holding.
  • Dudley Capital Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Dudley Capital Management's Merck position peaked at $2.55M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Dudley Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.